Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70 (0.87%) Dr. Reddys Laboratories informs about press release
Date: 16-09-2020Dr. Reddys Laboratories has informed that it has enclosed press release titled, ‘RDIF and Dr. Reddys to cooperate on clinical trials and supply of 100 million doses of Sputnik V vaccine to India’.
The above information is a part of company’s filings submitted to BSE.